Company / Finance

Ginkgo Bioworks Holdings, Inc.

DNA · NYSE

Ginkgo has moved from broad synthetic-biology promise toward a harder profitability test.

Latest ReportJun 5, 2026Ginkgo Bioworks Pivot: Analyzing Synthetic Biology Profitability Shifts Toward Biosecurity Service ContractsView report ->Total Reports1Published reportView all ->Active Discussions0No visible comments yetView discussions ->Member WorkspaceLockedFinancials, timeline, comparisons, scorecard, and discussion require a paid login.View access ->
Admin-only preview

Valuation is limited to admins for now.

The valuation workbench is hidden from non-admin users until market-data licensing and trust disclosures are production-ready.